Atlas Trials

40Hz tACS in Treating Cognitive Function and Modulating Neurophysiology of Patients With Alzheimer's Disease

Clinical trial NCT05723172 · UNKNOWN

Trial details

NCT number
NCT05723172
Sponsor
Che-Sheng Chu
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Alzheimer Disease
Start date
2023-09-01
Primary completion
2025-07-31
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.